AMITYVILLE, N.Y. & NEW YORK--(BUSINESS WIRE)--Topix Pharmaceuticals, Inc., a leading provider of innovative therapeutic and cosmetic skin care products, today announced that it has partnered with New Mountain Capital, LLC, a growth-oriented investment firm that currently manages over $15 billion in assets.
Headquartered in Amityville, NY, Topix has developed, manufactured and marketed highly-innovative and clinically-validated topical skin care products for over 30 years. Recognized by physicians for the high quality of its products, Topix is uniquely positioned due to its best-in-class formulation capabilities and proprietary product portfolio developed to meet the in-office dispensing needs of physicians and their patients.
Topix’s product portfolio addresses a wide array of skin health conditions and includes leading brands ReplenixTM, CitrixTM, GlycolixTM, and ReBrightalyzeTM as well as customized, private label solutions for the professionally dispensed market. Topix utilizes its own state-of-the-art, GMP-compliant facilities to research, develop, manufacture and test its products to the highest quality standards.
New Mountain, a New York-based private equity firm, identified Topix through a proactive focus in the life sciences and aesthetics industries. New Mountain is providing Topix with significant financial and strategic resources to support future growth initiatives which include new product development and acquisitions.
“Topix is the high quality leader in its space, and we are excited to partner with the Topix team to support the next phase of growth,” said Andre Moura, Managing Director at New Mountain Capital. “We look forward to working closely with management to help the Company realize its full growth potential by investing in new products, new channel strategies, new technologies and acquisitions, while maintaining the high level of quality and customer service which have always been the hallmarks of Topix’s success.”
“New Mountain is the perfect partner to help Topix execute on its growth plans,” said Burt Shaffer, President and CEO of Topix. “New Mountain is known for its focus on business building, and Topix will have deep resources at its disposal to help us achieve our strategic growth objectives. We look forward to our partnership and the benefits it will yield for our customers and employees.”
With over 30 years of skin care experience, Topix has a well-established and expanding presence in the physician dispensed marketplace. The company's primary therapeutic focus is dermatology with an innovative skin care product portfolio utilized in treating a wide array of skin conditions. Topix is dedicated to delivering innovative, clinically relevant topical skin care solutions that meet the needs of direct-dispensing physician partners and their patients. For more information on Topix, please visit: http://www.topixpharm.com/
About New Mountain Capital
New Mountain Capital is a New York based investment firm that emphasizes business building and growth, rather than debt, as it pursues long-term capital appreciation. The firm currently manages private equity, public equity, and credit funds with over $15 billion in aggregate capital commitments. New Mountain seeks out what it believes to be the highest quality growth leaders in carefully selected industry sectors and then works intensively with management to build the value of these companies. For more information on New Mountain Capital, please visit http://www.newmountaincapital.com/